$PTGX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Protagonist Therapeutics, Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Protagonist Therapeutics, Inc. Get notifications about new insider transactions in Protagonist Therapeutics, Inc for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20 2017 | PTGX | Protagonist Therap ... | O'Neil Thomas P. | Chief Financial Off ... | Buy | M | 4.21 | 4,000 | 16,840 | 8,000 | 4 K to 8 K (+100.00 %) |
| Dec 20 2017 | PTGX | Protagonist Therap ... | O'Neil Thomas P. | Chief Financial Off ... | Buy | M | 1.16 | 4,000 | 4,640 | 4,000 | 0 to 4 K |
| Dec 19 2017 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Option Exercise | A | 17.57 | 24,000 | 421,680 | 24,000 | |
| Dec 01 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | M | 1.89 | 875 | 1,654 | 12,350 | |
| Dec 01 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Sell | S | 20.00 | 875 | 17,500 | 3,822 | 4.7 K to 3.8 K (-18.63 %) |
| Dec 01 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Grant | A | 1.89 | 875 | 1,654 | 4,697 | 3.8 K to 4.7 K (+22.89 %) |
| Nov 15 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | M | 1.89 | 3,500 | 6,615 | 13,225 | |
| Nov 15 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | M | 4.21 | 3,500 | 14,735 | 38,831 | |
| Nov 15 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Sell | S | 16.97 | 3,500 | 59,381 | 3,822 | 7.3 K to 3.8 K (-47.80 %) |
| Nov 15 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Buy | M | 1.89 | 3,500 | 6,615 | 7,322 | 3.8 K to 7.3 K (+91.58 %) |
| Nov 15 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Sell | S | 16.97 | 3,500 | 59,381 | 3,822 | 7.3 K to 3.8 K (-47.80 %) |
| Nov 15 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Buy | M | 4.21 | 3,500 | 14,735 | 7,322 | 3.8 K to 7.3 K (+91.58 %) |
| Oct 10 2017 | PTGX | Protagonist Therap ... | Shames Richard S. | Chief Medical Offic ... | Option Exercise | M | 4.21 | 2,017 | 8,492 | 36,802 | |
| Oct 10 2017 | PTGX | Protagonist Therap ... | Shames Richard S. | Chief Medical Offic ... | Sell | S | 19.00 | 2,017 | 38,323 | 0 | 2 K to 0 (-100.00 %) |
| Oct 10 2017 | PTGX | Protagonist Therap ... | Shames Richard S. | Chief Medical Offic ... | Buy | M | 4.21 | 2,017 | 8,492 | 2,017 | 0 to 2 K |
| Sep 12 2017 | PTGX | Protagonist Therap ... | Shames Richard S. | Chief Medical Offic ... | Sell | S | 14.31 | 3,687 | 52,753 | 0 | 3.7 K to 0 (-100.00 %) |
| Aug 30 2017 | PTGX | Protagonist Therap ... | Shames Richard S. | Chief Medical Offic ... | Option Exercise | M | 4.21 | 1,512 | 6,366 | 38,819 | |
| Aug 30 2017 | PTGX | Protagonist Therap ... | Shames Richard S. | Chief Medical Offic ... | Sell | S | 17.00 | 1,512 | 25,704 | 1,865 | 3.4 K to 1.9 K (-44.77 %) |
| Aug 30 2017 | PTGX | Protagonist Therap ... | Shames Richard S. | Chief Medical Offic ... | Buy | M | 4.21 | 1,512 | 6,366 | 3,377 | 1.9 K to 3.4 K (+81.07 %) |
| Aug 29 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | M | 4.21 | 3,500 | 14,735 | 42,331 | |
| Aug 29 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Sell | S | 15.00 | 3,500 | 52,500 | 2,000 | 5.5 K to 2 K (-63.64 %) |
| Aug 29 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Buy | M | 4.21 | 3,500 | 14,735 | 5,500 | 2 K to 5.5 K (+175.00 %) |
| Jul 12 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | M | 1.89 | 3,500 | 6,615 | 16,725 | |
| Jul 12 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Sell | S | 12.68 | 3,500 | 44,380 | 2,000 | 5.5 K to 2 K (-63.64 %) |
| Jul 12 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Buy | M | 1.89 | 3,500 | 6,615 | 5,500 | 2 K to 5.5 K (+175.00 %) |
| Jun 15 2017 | PTGX | Protagonist Therap ... | Williams Lewis T | Director | Option Exercise | A | 10.84 | 24,000 | 260,160 | 24,000 | |
| May 26 2017 | PTGX | Protagonist Therap ... | Waddill William D. | Director | Option Exercise | A | 8.59 | 12,000 | 103,080 | 12,000 | |
| May 26 2017 | PTGX | Protagonist Therap ... | Shanafelt Armen | Director | Option Exercise | A | 8.59 | 12,000 | 103,080 | 12,000 | |
| May 26 2017 | PTGX | Protagonist Therap ... | SELICK HAROLD E | Director | Option Exercise | A | 8.59 | 12,000 | 103,080 | 12,000 | |
| May 26 2017 | PTGX | Protagonist Therap ... | KHOSLA CHAITAN PHD | Director | Option Exercise | A | 8.59 | 12,000 | 103,080 | 12,000 | |
| May 26 2017 | PTGX | Protagonist Therap ... | Papanek Julie | Director | Option Exercise | A | 8.59 | 12,000 | 103,080 | 12,000 | |
| May 10 2017 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Option Exercise | M | 1.16 | 19,099 | 22,155 | 78,203 | |
| May 10 2017 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Buy | M | 1.16 | 19,099 | 22,155 | 190,437 | 171.3 K to 190.4 K (+11.15 %) |
| Apr 07 2017 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Option Exercise | M | 1.16 | 20,000 | 23,200 | 97,302 | |
| Apr 07 2017 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Buy | M | 1.16 | 20,000 | 23,200 | 171,338 | 151.3 K to 171.3 K (+13.22 %) |
| Mar 13 2017 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Option Exercise | M | 0.87 | 16,362 | 14,235 | 11,297 | |
| Mar 13 2017 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Buy | M | 0.87 | 16,362 | 14,235 | 151,338 | 135 K to 151.3 K (+12.12 %) |
| Oct 13 2016 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Option Exercise | A | 21.58 | 320,000 | 6,905,600 | 320,000 | |
| Oct 13 2016 | PTGX | Protagonist Therap ... | Shames Richard S. | Chief Medical Offic ... | Option Exercise | A | 21.58 | 65,000 | 1,402,700 | 65,000 | |
| Oct 13 2016 | PTGX | Protagonist Therap ... | O'Neil Thomas P. | Chief Financial Off ... | Option Exercise | A | 21.58 | 45,000 | 971,100 | 45,000 | |
| Oct 13 2016 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | A | 21.58 | 65,000 | 1,402,700 | 65,000 | |
| Oct 13 2016 | PTGX | Protagonist Therap ... | HODDER WILLIAM A | Sr. VP - Corporate ... | Option Exercise | A | 21.58 | 65,000 | 1,402,700 | 65,000 | |
| Sep 15 2016 | PTGX | Protagonist Therap ... | Waddill William D. | Director | Option Exercise | A | 12.88 | 24,000 | 309,120 | 24,000 | |
| Sep 15 2016 | PTGX | Protagonist Therap ... | Shanafelt Armen | Director | Option Exercise | A | 12.88 | 24,000 | 309,120 | 24,000 | |
| Sep 15 2016 | PTGX | Protagonist Therap ... | SELICK HAROLD E | Director | Option Exercise | A | 12.88 | 24,000 | 309,120 | 24,000 | |
| Sep 15 2016 | PTGX | Protagonist Therap ... | KHOSLA CHAITAN PHD | Director | Option Exercise | A | 12.88 | 24,000 | 309,120 | 24,000 | |
| Sep 15 2016 | PTGX | Protagonist Therap ... | Papanek Julie | Director | Option Exercise | A | 12.88 | 24,000 | 309,120 | 24,000 | |
| Aug 18 2016 | PTGX | Protagonist Therap ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 13,054,830 | 0 | 0 | |
| Aug 18 2016 | PTGX | Protagonist Therap ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 14,000,000 | 0 | 0 | |
| Aug 18 2016 | PTGX | Protagonist Therap ... | JOHNSON & JOHNSON | 10% Owner | Buy | P | 12.00 | 583,333 | 6,999,996 | 2,449,183 | 1.9 M to 2.4 M (+31.26 %) |
| Aug 18 2016 | PTGX | Protagonist Therap ... | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 900,333 | 0 | 1,865,850 | 965.5 K to 1.9 M (+93.25 %) |
| Aug 18 2016 | PTGX | Protagonist Therap ... | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 965,517 | 0 | 965,517 | 0 to 965.5 K |
| Aug 16 2016 | PTGX | Protagonist Therap ... | Papanek Julie | Director | Option Exercise | C | 0.00 | 27,113,877 | 0 | 0 | |
| Aug 16 2016 | PTGX | Protagonist Therap ... | Papanek Julie | Director | Buy | P | 12.00 | 583,333 | 6,999,996 | 2,453,255 | 1.9 M to 2.5 M (+31.20 %) |
| Aug 16 2016 | PTGX | Protagonist Therap ... | Papanek Julie | Director | Buy | C | 0.00 | 1,869,922 | 0 | 1,869,922 | 0 to 1.9 M |
| Aug 16 2016 | PTGX | Protagonist Therap ... | CANAAN X L.P. | Director | Option Exercise | C | 0.00 | 27,113,877 | 0 | 0 | |
| Aug 16 2016 | PTGX | Protagonist Therap ... | CANAAN X L.P. | Director | Buy | P | 12.00 | 583,333 | 6,999,996 | 2,453,255 | 1.9 M to 2.5 M (+31.20 %) |
| Aug 16 2016 | PTGX | Protagonist Therap ... | CANAAN X L.P. | Director | Buy | C | 0.00 | 1,869,922 | 0 | 1,869,922 | 0 to 1.9 M |
| Aug 16 2016 | PTGX | Protagonist Therap ... | Shanafelt Armen | Director | Option Exercise | C | 0.00 | 9,841,333 | 0 | 0 | |
| Aug 16 2016 | PTGX | Protagonist Therap ... | Shanafelt Armen | Director | Option Exercise | C | 0.00 | 9,142,857 | 0 | 0 | |
| Aug 16 2016 | PTGX | Protagonist Therap ... | Shanafelt Armen | Director | Option Exercise | C | 0.00 | 3,000,000 | 0 | 0 | |
| Aug 16 2016 | PTGX | Protagonist Therap ... | Shanafelt Armen | Director | Buy | P | 12.00 | 583,333 | 6,999,996 | 2,099,482 | 1.5 M to 2.1 M (+38.47 %) |
| Aug 16 2016 | PTGX | Protagonist Therap ... | Shanafelt Armen | Director | Buy | C | 0.00 | 678,712 | 0 | 1,516,149 | 837.4 K to 1.5 M (+81.05 %) |
| Aug 16 2016 | PTGX | Protagonist Therap ... | Shanafelt Armen | Director | Buy | C | 0.00 | 630,541 | 0 | 837,437 | 206.9 K to 837.4 K (+304.76 %) |
| Aug 16 2016 | PTGX | Protagonist Therap ... | Shanafelt Armen | Director | Buy | C | 0.00 | 206,896 | 0 | 206,896 | 0 to 206.9 K |
| Aug 16 2016 | PTGX | Protagonist Therap ... | LV Management Group, LLC | 10% Owner | Option Exercise | C | 0.00 | 9,841,333 | 0 | 0 | |
| Aug 16 2016 | PTGX | Protagonist Therap ... | LV Management Group, LLC | 10% Owner | Option Exercise | C | 0.00 | 9,142,857 | 0 | 0 | |
| Aug 16 2016 | PTGX | Protagonist Therap ... | LV Management Group, LLC | 10% Owner | Option Exercise | C | 0.00 | 3,000,000 | 0 | 0 | |
| Aug 16 2016 | PTGX | Protagonist Therap ... | LV Management Group, LLC | 10% Owner | Buy | P | 12.00 | 583,333 | 6,999,996 | 2,099,482 | 1.5 M to 2.1 M (+38.47 %) |
| Aug 16 2016 | PTGX | Protagonist Therap ... | LV Management Group, LLC | 10% Owner | Buy | C | 0.00 | 678,712 | 0 | 1,516,149 | 837.4 K to 1.5 M (+81.05 %) |
| Aug 16 2016 | PTGX | Protagonist Therap ... | LV Management Group, LLC | 10% Owner | Buy | C | 0.00 | 630,541 | 0 | 837,437 | 206.9 K to 837.4 K (+304.76 %) |
| Aug 16 2016 | PTGX | Protagonist Therap ... | LV Management Group, LLC | 10% Owner | Buy | C | 0.00 | 206,896 | 0 | 206,896 | 0 to 206.9 K |